Luca Quattrini - Publications

β-Cyclodextrin nanosponges for the ocular delivery of therapeutic Micro-RNA in a Mouse model of retinitis Pigmentosa: A proof of concept study.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: May 20, 2024

Complexing the Marine Sesquiterpene Euplotin C by Means of Cyclodextrin-Based Nanosponges: A Preliminary Investigation.

Journal: Marine drugs

Published: September 22, 2022

Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.

Journal: International journal of molecular sciences

Published: March 17, 2021

Aldehyde Dehydrogenases and Prostate Cancer: Shedding Light on Isoform Distribution to Reveal Druggable Target.

Journal: Biomedicines

Published: October 22, 2020

Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: May 13, 2020

Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells.

Journal: Journal of medicinal chemistry

Published: April 01, 2020

Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-a]pyridines against the 1A Family.

Journal: ACS medicinal chemistry letters

Published: January 03, 2020

Synthesis and investigation of polyhydroxylated pyrrolidine derivatives as novel chemotypes showing dual activity as glucosidase and aldose reductase inhibitors.

Journal: Bioorganic chemistry

Published: August 02, 2019

Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation.

Journal: Scientific reports

Published: February 20, 2019

Aldose reductase inhibitors: 2013-present.

Journal: Expert opinion on therapeutic patents

Published: February 15, 2019

Soyasaponins from Zolfino bean as aldose reductase differential inhibitors.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: February 09, 2019

A 2,3-diphenylpyrido[1,2-a] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-α.

Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Published: February 07, 2019